Pathologist Bio-Medical Laboratories, Pllc

CLIA Laboratory Citation Details

2
Total Citations
14
Total Deficiencyies
6
Unique D-Tags
CMS Certification Number 45D2023046
Address 3600 Gaston Ave, Wadley Tower, Suite 261, Dallas, TX, 75246
City Dallas
State TX
Zip Code75246
Phone(214) 818-9100

Citation History (2 surveys)

Survey - September 30, 2021

Survey Type: Standard

Survey Event ID: Z1BV11

Deficiency Tags: D0000 D2138 D2138 D2142 D2144 D0000 D2142 D2144 D2145 D2145

Summary:

Summary Statement of Deficiencies D0000 Laboratory representatives were present at the entrance conference. The survey process was discussed. An opportunity for questions and comments was given. The exit conference was held with the laboratory representatives. The laboratory was found to be in substantial compliance for the specialties/subspecialties for which it was surveyed. The standard level deficiencies cited were discussed. The process for submitting the corrections was explained. CMS form 2567 will be emailed from the Texas Health and Human Services Commission, Health Facility Compliance Arlington Group. Note: The CMS-2567 (Statement of Deficiencies) is an official, legal document. All information must remain unchanged except for entering the

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - November 1, 2019

Survey Type: Standard

Survey Event ID: BGC511

Deficiency Tags: D0000 D6107 D0000 D6107

Summary:

Summary Statement of Deficiencies D0000 The Director of Operations Support and Consult Coordinator were at the entrance conference conducted 11/01/2019. The survey process was discussed. An opportunity for questions and comments was given. Exit conference was held with the Director of Operations Support and Consult Coordinator on 11/01/2019. The laboratory was found to be in substantial compliance for the specialties/subspecialties for which it was surveyed. The standard level deficiency cited was discussed. The process for submitting the corrections was explained. D6107 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1445(e)(15) The laboratory director must specify, in writing, the responsibilities and duties of each consultant and each supervisor, as well as each person engaged in the performance of the preanalytic, analytic, and postanalytic phases of testing, that identifies which examinations and procedures each individual is authorized to perform, whether supervision is required for specimen processing, test performance or result reporting and whether supervisory or director review is required prior to reporting patient test results. This STANDARD is not met as evidenced by: Based on review of the CMS 209 form, competency assessments, delegation of duties documents, and in interview with staff, the laboratory director failed to specify, in writing, the delegated duties of the cytology general supervisor to include performing competency assessments on testing personnel. Findings included: 1. Review of the CMS 209 form included one cytology general supervisor (CT-GS1), who was also a testing person, and four other cytology technologists. 2. Review of competency assessments for the four cytology technologists revealed the CT-GS1 performed and documented the evaluations in 2018 and 2019. 3. Review of written delegation of duties documents did not include the laboratory director delegating to the CT-GS1 to Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- perform and document competency assessment for the other cytology technologists. 4. During an interview on 11/01/2019 at 11:00 am, the Director of Operations Support confirmed the laboratory director did not specify, in writing, the delegated duties of the cytology general supervisor to include performing competency assessments on testing personnel. Word Key: CMS - Centers for Medicare and Medicaid Services -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access